Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Revenue

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹1,196 Cr₹10,145 Cr₹884 Cr₹884 Cr

What is the latest Revenue of CORONA REMEDIES ?

The latest Revenue ratio of CORONA REMEDIES is ₹1,196 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,196 Cr
Mar2025₹10,145 Cr
Mar2024₹884 Cr
Mar2023₹884 Cr

How is Revenue of CORONA REMEDIES Trending?

Years Revenue % Change
Mar2026 ₹1,196 Cr
-88.21
Mar2025 ₹10,145 Cr
1,047.53
Mar2024 ₹884 Cr
0.00
Mar2023 ₹884 Cr -

Compare Revenue of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,388.4 Cr -0.6% -3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.6%

-3%

NA
SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses